The pharmaceutical industry is one of the pillars of the Hungarian economy and has been identified as a key growth driver for the future by the…

Hungary’s two largest pharma firms, Egis Pharmaceuticals and Gedeon Richter, are stepping up their biosimilars offering; providing the European…

Sheron Lin, president of Daiichi Sankyo Taiwan, elaborates on the affiliate’s tactical positioning in the region and a leading market for clinical…

Yuichi Yomasu, president of Daiichi Sankyo China, shares his first impressions of the dynamic but complex Chinese market since he assumed position ten…

This is the first in a series of articles examining what it takes to be a country manager of a multinational pharma company in some of the world’s…

Andras Gizur, president China & APAC for Gedeon Richter, shares his insights on the current market environment in China following the spate of…

Dae Jung Kim, president of Daiichi Sankyo Korea provides an insight into the rationale behind the company’s focus on the cardiovascular therapeutic…

Emmanuel Eumont, general manager of Gedeon Richter France, discusses the group’s leading position in women’s health, its external growth strategy,…

Dino Mangion, head of Malta Operations at Medichem-Combino Pharm, has been leading the company through the harmonization of operations between…

Poul Sorensen, director of Geistlich Pharma in Brazil, details the importance of educational activities for Geistlich’s business, the affiliate’s…

In an exclusive interview, Jarbas Barbosa da Silva, Director-President of the Brazilian Health Regulatory Agency (ANVISA), discusses some of the key…

Paul Note, CEO of leading Swiss tissue and bone regeneration specialist Geistlich, discusses how the medtech industry can safeguard success against a…